Guardian Capital LP Novo Nordisk A S Put Options Transaction History

Guardian Capital LP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 08, 2024	BUY	$87.78 - $105.45 $3.09 Million - $3.71 Million	35,200 New	35,200 $3.64 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $3.96 Million - $4.76 Million	29,900 New	29,900 $4.76 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $114,336 - $140,316	1,200 Added 3.2%	38,700 $2.02 Million
Q2 2022 Aug 12, 2022	BUY	$103.24 - $121.81 $227,128 - $267,982	2,200 Added 6.23%	37,500 $1.2 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $204,820 - $247,588	2,200 Added 6.65%	35,300 $1.18 Million
Q4 2021 Feb 10, 2022	BUY	$95.88 - $117.08 $373,932 - $456,612	3,900 Added 13.36%	33,100 $627,000
Q3 2021 Nov 15, 2021	SELL	$84.42 - $106.62 $101,304 - $127,944	-1,200 Reduced 3.95%	29,200 $1.07 Million
Q2 2021 Aug 17, 2021	BUY	$67.66 - $84.76 $2.06 Million - $2.58 Million	30,400 New	30,400 $189,000

1,991

318M

5.23M

4.97M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $263B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Guardian Capital LP, based on Form 13F filings with the SEC.

Stay updated on Guardian Capital LP with notifications on news.